- Info
- Significant Ownership
- Insider Ownership
Significant Ownership of New Enterprise Associates 17, L.P.
- Signature - Title
- /s/ Zachary Bambach - Zachary Bambach as attorney-in-fact for Anthony A. Florence, Jr., Managing Partner and Co-Chief Executive Officer
- Location
- Timonium, MD
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by New Enterprise Associates 17, L.P..
Follow Filing Activity
Follow New Enterprise Associates 17, L.P. and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of New Enterprise Associates 17, L.P.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SpyGlass Pharma, Inc. | Common Stock, $0.00001 par value per share | 22% | 7,393,823 | Ali Behbahani | 09 Feb 2026 | ||||
| KRRO | Korro Bio, Inc. | Common Stock, par value $0.001 per share | 9.9% | $17,130,522 | 1,456,677 | Ali Behbahani | 10 Mar 2026 | ||
| GLUE | Monte Rosa Therapeutics, Inc. | Common Stock, par value $0.0001 per share | 9.7% | $143,153,471 | 7,797,030 | Ali Behbahani | 17 Mar 2026 | ||
| MBX | MBX Biosciences, Inc. | Common Stock, par value $0.0001 per share | 8.1% | $63,340,795 | 3,619,474 | Edward T. Mathers | 06 Nov 2025 | ||
| IVA | Inventiva S.A. | Ordinary Shares, (euro)0.01 par value per share | 4.9% | $57,827,646 | +$6,303,642 | 9,372,390 | +12% | New Enterprise Associates 17, L.P. | 30 Mar 2026 |
| NEUE | NeueHealth, Inc. | Common Stock, $0.0001 par value | 0% | $0 | -$50,344,650 | 0 | -100% | New Enterprise Associates 15, L.P. | 02 Oct 2025 |
Schedules 13D/G Reported by New Enterprise Associates 17, L.P.:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.